Concepedia

William Z. Potter

WZ

Statistics

Publications

63

Citations

4.8K

H-Index

32

Active since

1974

Affiliations

National Institute of Mental Health(Current)

Eli Lilly (United States)

University of California, San Francisco

National Institutes of Health

Yale University

William Z. Potter is an author at National Institute of Mental Health specializing in medicine, pharmacology, and psychopharmacology.

ORCID

Publications per year

1974–2026

63

Publications

63

Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia

Anantha Shekhar, William Z. Potter, Jeffrey Lightfoot et al. · American Journal of Psychiatry · 2008 · 559 citations

, , +17

Acetaminophen‐induced hepatic injury: Protective role of glutathione in man and rationale for therapy

Jerry R. Mitchell, Snorri S. Thorgeirsson, William Z. Potter et al. · Clinical Pharmacology & Therapeutics · 1974 · 533 citations

, , +17

Results From 2 Proof-of-Concept, Placebo-Controlled Studies of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder

Thomas Spencer, John H. Heiligenstein, Joseph Biederman et al. · The Journal of Clinical Psychiatry · 2002 · 336 citations

, , +17

Acetaminophen-Induced Hepatic Necrosis V. Correlation of Hepatic Necrosis, Covalent Binding and Glutathione Depletion in Hamsters

William Z. Potter, S.S. Thorgeirsson, David J. Jollow et al. · Pharmacology · 2008 · 304 citations

, , +17

Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydrazine metabolites

Jerry R. Mitchell, Unnur P. Thorgeirsson, Martin Black et al. · Clinical Pharmacology & Therapeutics · 1975 · 303 citations

, , +12

1–5 of 63